We are live on
!
Find out more
CDH
Charles D. Hyman Portfolio holdings
AUM
$1.79B
1-Year Est. Return
17.18%
This Fund
S&P 500
This Quarter
Est. Return
+3.7%
1 Year Est. Return
+17.18%
3 Year Est. Return
+36.79%
5 Year Est. Return
+95.96%
10 Year Est. Return
+199.04%
AUM
$805M
AUM Growth
+$21.6M
(+2.8%)
Cap. Flow
-$2.18M
Cap. Flow
% of AUM
-0.27%
Top 10 Holdings %
Top 10 Hldgs %
31.26%
Holding
161
New
6
Increased
33
Reduced
69
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley Series I Preferred Stock
MS.PRI
|
+$4.76M |
| 2 |
DuPont de Nemours
DD
|
+$2.21M |
| 3 |
PayPal
PYPL
|
+$2.18M |
| 4 |
AT&T
T
|
+$1.29M |
| 5 |
JPMorgan Chase
JPM
|
+$434K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$2.11M |
| 2 |
GE Aerospace
GE
|
+$983K |
| 3 |
Johnson & Johnson
JNJ
|
+$685K |
| 4 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$636K |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$587K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 22.91% |
| 2 | Financials | 10.72% |
| 3 | Consumer Staples | 9.87% |
| 4 | Healthcare | 9.37% |
| 5 | Technology | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Eaton
ETN
$157B
| $200K | 0.02% |
2,610
| – | – |
|
152
Alerian MLP ETF
AMLP
$13B
| $146K | 0.02% |
2,600
| – | – |
|
153
Opko Health
OPK
$921M
| $124K | 0.02% |
18,119
| – | – |
|
154
Matinas BioPharma
MTNB
$1.55M
| $105K | 0.01% |
1,596
| – | – |
|
|
NCV
155
Virtus Convertible & Income Fund
NCV
$374M
| $95K | 0.01% |
3,350
| – | – |
|
|
SMRT
156
DELISTED
Stein Mart Inc
SMRT
| $51K | 0.01% |
38,900
+7,000
| +22% | +$9.08K |
|
|
NVIV
157
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
| $43K | 0.01% |
2
| – | – |
|
|
GNMX
158
DELISTED
Aevi Genomic Medicine Inc
GNMX
| $19K | ﹤0.01% |
15,143
| – | – |
|
|
K
159
DELISTED
Kellanova
K
| – | – |
-3,302
| Closed | -$215K |
|
|
PRA
160
DELISTED
ProAssurance
PRA
| – | – |
-3,600
| Closed | -$219K |
|
|
DD
161
DELISTED
Du Pont De Nemours E I
DD
| – | – |
-26,120
| Closed | -$2.11M |
|
Similar funds
AT
BPCA
HIG
H
LFDLE
PRIG
PO
GC
Charles D. Hyman's Q3 2017 Portfolio in Review
As of Q3 2017, Charles D. Hyman held 161 positions worth $805M, up 2.8% from $783M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Charles D. Hyman's Q3 2017 filing shows 6 new, 33 increased, 69 reduced and 3 closed positions. Its largest new stake was Morgan Stanley Series I Preferred Stock: 167,415 shares worth $4.75M. The largest sale was Du Pont De Nemours E I, an estimated $2.11M.
By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Staples.
- Charles D. Hyman's largest Q3 2017 buy was Morgan Stanley Series I Preferred Stock: 167,415 shares worth $4.75M.
- Charles D. Hyman added most to AT&T in Q3 2017, an estimated $1.29M increase.
- Charles D. Hyman's biggest Q3 2017 reduction was GE Aerospace, cutting an estimated $983K.
- Charles D. Hyman fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $2.11M.
- Charles D. Hyman's ten largest holdings make up 31% of its $805M portfolio in Q3 2017.
- Charles D. Hyman opened 6 new positions and closed 3 in Q3 2017.
- Charles D. Hyman's portfolio value rose 2.8% quarter-over-quarter to $805M.
Based on Charles D. Hyman's 13F filing for Q3 2017, filed 13 Nov 2017.